Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$465M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$445M |
| 4 |
Kenvue
KVUE
|
+$434M |
| 5 |
Micron Technology
MU
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.24B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Microsoft
MSFT
|
+$1.56B |
| 4 |
PepsiCo
PEP
|
+$1.34B |
| 5 |
JPMorgan Chase
JPM
|
+$1.34B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 43.54% |
| 2 | Technology | 19.7% |
| 3 | Financials | 7.47% |
| 4 | Consumer Discretionary | 6.7% |
| 5 | Communication Services | 6.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4626
Vera Bradley
VRA
$147M
| $60.1K | ﹤0.01% |
24,817
| – | – |
2022 Q3
13 quarters
|
|
|
ZOCT
4627
Innovator Equity Defined Protection ETF - 1 Yr October
ZOCT
$106M
| $59.7K | ﹤0.01% |
2,223
-3,343
| -60% | -$89.3K |
2024 Q4
4 quarters
|
|
4628
Vanguard ESG US Stock ETF
ESGV
$13.6B
| $59.6K | ﹤0.01% |
+493
| New | +$59.1K |
2025 Q4
0 quarters
|
|
4629
Value Line
VALU
$380M
| $59.5K | ﹤0.01% |
1,547
+415
| +37% | +$15.7K |
2019 Q1
27 quarters
|
|
4630
Sprott Physical Silver Trust
PSLV
$12.4B
| $59.1K | ﹤0.01% |
2,500
-46,656
| -95% | -$855K |
2020 Q2
22 quarters
|
|
4631
Acrivon Therapeutics
ACRV
$85.3M
| $58.8K | ﹤0.01% |
24,402
+4,437
| +22% | +$9.64K |
2022 Q4
12 quarters
|
|
4632
Cognyte Software
CGNT
$645M
| $58.6K | ﹤0.01% |
6,233
+216
| +4% | +$1.87K |
2022 Q1
15 quarters
|
|
|
MSB
4633
Mesabi Trust
MSB
$248M
| $57.8K | ﹤0.01% |
+1,500
| New | +$50.8K |
2025 Q4
0 quarters
|
|
4634
Novartis
NVS
$268B
| $56.4K | ﹤0.01% |
409
-154
| -27% | -$20.2K |
2013 Q2
50 quarters
|
|
4635
Suburban Propane Partners
SPH
$1.11B
| $55.8K | ﹤0.01% |
3,007
-135
| -4% | -$2.53K |
2013 Q2
50 quarters
|
|
4636
Seanergy Maritime Holdings
SHIP
$386M
| $55.7K | ﹤0.01% |
6,039
-13,323
| -69% | -$121K |
2022 Q1
15 quarters
|
|
4637
Neumora Therapeutics
NMRA
$93.9M
| $55.4K | ﹤0.01% |
30,924
+20,683
| +202% | +$45.3K |
2023 Q4
8 quarters
|
|
4638
Traeger
COOK
$149M
| $55.3K | ﹤0.01% |
1,024
+93
| +10% | +$4.53K |
2022 Q1
15 quarters
|
|
4639
Freightos
CRGO
$50.6M
| $55K | ﹤0.01% |
+24,138
| New | +$78.4K |
2025 Q4
0 quarters
|
|
4640
Innovator US Equity Accelerated 9 Buffer ETF January
XBJA
$93.9M
| $54.7K | ﹤0.01% |
1,712
-238
| -12% | -$7.52K |
2024 Q3
5 quarters
|
|
4641
Global E Online
GLBE
$6.6B
| $54.6K | ﹤0.01% |
1,389
-326,304
| -100% | -$12.1M |
2023 Q2
10 quarters
|
|
4642
Silicom
SILC
$345M
| $53.9K | ﹤0.01% |
3,670
+927
| +34% | +$14.5K |
2015 Q2
42 quarters
|
|
4643
FT Vest US Equity Deep Buffer ETF August
DAUG
$436M
| $53.8K | ﹤0.01% |
1,214
+884
| +268% | +$38.8K |
2024 Q3
5 quarters
|
|
4644
Innovator US Equity Power Buffer ETF November
PNOV
$865M
| $53.7K | ﹤0.01% |
1,286
-2,865
| -69% | -$119K |
2025 Q1
3 quarters
|
|
4645
AMREP Corp
AXR
$115M
| $52.5K | ﹤0.01% |
2,795
+2,478
| +782% | +$53.5K |
2025 Q3
1 quarter
|
|
4646
Mobile Infrastructure Corp
BEEP
$106M
| $52.2K | ﹤0.01% |
20,468
-601
| -3% | -$1.88K |
2024 Q4
4 quarters
|
|
4647
HSBC
HSBC
$329B
| $52K | ﹤0.01% |
661
-14,424
| -96% | -$1.03M |
2013 Q2
50 quarters
|
|
4648
Innovator US Equity Power Buffer ETF July
PJUL
$1.3B
| $51.9K | ﹤0.01% |
1,117
+1,004
| +888% | +$46.1K |
2025 Q3
1 quarter
|
|
4649
CALL
Western Digital
WDC
$150B
| $51.7K | ﹤0.01% |
300
-53,100
| -99% | -$8.05M |
2025 Q3
1 quarter
|
|
4650
Torrid Holdings
CURV
$249M
| $51.6K | ﹤0.01% |
52,769
+5,195
| +11% | +$6.64K |
2022 Q1
15 quarters
|
|
Similar funds
Barclays's Q4 2025 Portfolio in Review
As of Q4 2025, Barclays held 5,847 positions worth $417B, down 9.7% from $461B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Barclays withdrew a net $23.5B in Q4 2025, closing 641 positions and reducing 1,714 holdings. Its most notable exit was Verona Pharma, an estimated $149M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 44% of assets, down from 44% a quarter earlier, followed by Technology and Financials.
Against the trend, Barclays opened a new position in The Magnum Ice Cream Company N.V. worth $156M.
- Barclays's largest Q4 2025 buy was The Magnum Ice Cream Company N.V.: 9,862,859 shares worth $156M.
- Barclays added most to Gilead Sciences in Q4 2025, an estimated $479M increase.
- Barclays's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $3.24B.
- Barclays fully exited Verona Pharma in Q4 2025, selling an estimated $149M.
- Barclays's ten largest holdings make up 35% of its $417B portfolio in Q4 2025.
- Barclays opened 403 new positions and closed 641 in Q4 2025.
- Barclays's portfolio value fell 9.7% quarter-over-quarter to $417B.
Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.